Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

NYSE:ICL - IL0002810146 - Common Stock

6.45 USD
-0.09 (-1.38%)
Last: 8/29/2025, 11:15:25 AM
Fundamental Rating

5

ICL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. ICL scores excellent on profitability, but there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ICL was profitable.
In the past year ICL had a positive cash flow from operations.
In the past 5 years ICL has always been profitable.
ICL had a positive operating cash flow in each of the past 5 years.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

With a decent Return On Assets value of 2.97%, ICL is doing good in the industry, outperforming 64.29% of the companies in the same industry.
ICL has a better Return On Equity (6.10%) than 69.05% of its industry peers.
ICL's Return On Invested Capital of 5.24% is fine compared to the rest of the industry. ICL outperforms 60.71% of its industry peers.
ICL had an Average Return On Invested Capital over the past 3 years of 13.86%. This is significantly above the industry average of 6.43%.
The last Return On Invested Capital (5.24%) for ICL is well below the 3 year average (13.86%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROIC 5.24%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

With a decent Profit Margin value of 5.28%, ICL is doing good in the industry, outperforming 71.43% of the companies in the same industry.
ICL's Profit Margin has declined in the last couple of years.
ICL's Operating Margin of 10.46% is fine compared to the rest of the industry. ICL outperforms 60.71% of its industry peers.
In the last couple of years the Operating Margin of ICL has declined.
ICL has a Gross Margin (32.29%) which is comparable to the rest of the industry.
ICL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICL is still creating some value.
Compared to 1 year ago, ICL has about the same amount of shares outstanding.
The number of shares outstanding for ICL has been increased compared to 5 years ago.
ICL has a better debt/assets ratio than last year.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ICL has an Altman-Z score of 2.41. This is not the best score and indicates that ICL is in the grey zone with still only limited risk for bankruptcy at the moment.
ICL's Altman-Z score of 2.41 is fine compared to the rest of the industry. ICL outperforms 66.67% of its industry peers.
The Debt to FCF ratio of ICL is 6.12, which is on the high side as it means it would take ICL, 6.12 years of fcf income to pay off all of its debts.
ICL has a better Debt to FCF ratio (6.12) than 76.19% of its industry peers.
ICL has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ICL has a better Debt to Equity ratio (0.42) than 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Altman-Z 2.41
ROIC/WACC0.68
WACC7.72%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.75 indicates that ICL should not have too much problems paying its short term obligations.
ICL's Current ratio of 1.75 is on the low side compared to the rest of the industry. ICL is outperformed by 60.71% of its industry peers.
A Quick Ratio of 1.05 indicates that ICL should not have too much problems paying its short term obligations.
ICL's Quick ratio of 1.05 is on the low side compared to the rest of the industry. ICL is outperformed by 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.05
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The earnings per share for ICL have decreased by -7.50% in the last year.
Looking at the last year, ICL shows a decrease in Revenue. The Revenue has decreased by -1.22% in the last year.
Measured over the past years, ICL shows a small growth in Revenue. The Revenue has been growing by 5.35% on average per year.
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%

3.2 Future

ICL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.56% yearly.
The Revenue is expected to grow by 3.93% on average over the next years.
EPS Next Y-3.39%
EPS Next 2Y12.89%
EPS Next 3Y12.56%
EPS Next 5YN/A
Revenue Next Year2.87%
Revenue Next 2Y4.16%
Revenue Next 3Y3.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.43 indicates a rather expensive valuation of ICL.
Based on the Price/Earnings ratio, ICL is valued a bit cheaper than 61.90% of the companies in the same industry.
ICL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.17.
ICL is valuated correctly with a Price/Forward Earnings ratio of 13.32.
ICL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICL is cheaper than 64.29% of the companies in the same industry.
ICL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.78.
Industry RankSector Rank
PE 17.43
Fwd PE 13.32
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ICL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ICL is cheaper than 73.81% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICL indicates a somewhat cheap valuation: ICL is cheaper than 73.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.49
EV/EBITDA 7.95
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ICL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ICL's earnings are expected to grow with 12.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.89%
EPS Next 3Y12.56%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.00%, ICL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.54, ICL pays a bit more dividend than its industry peers.
ICL's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

64.85% of the earnings are spent on dividend by ICL. This is not a sustainable payout ratio.
DP64.85%
EPS Next 2Y12.89%
EPS Next 3Y12.56%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (8/29/2025, 11:15:25 AM)

6.45

-0.09 (-1.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners23.58%
Inst Owner Change3.18%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap8.32B
Analysts47.5
Price Target0.07 (-98.91%)
Short Float %0.18%
Short Ratio1.77
Dividend
Industry RankSector Rank
Dividend Yield 3%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP64.85%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-03 2025-09-03 (0.0426)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.62%
Min EPS beat(2)-18.25%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)1.71%
Min EPS beat(4)-18.25%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)9.5%
EPS beat(12)7
Avg EPS beat(12)6.24%
EPS beat(16)11
Avg EPS beat(16)18.56%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.14%
PT rev (3m)26.27%
EPS NQ rev (1m)-14.06%
EPS NQ rev (3m)-15.38%
EPS NY rev (1m)-16.24%
EPS NY rev (3m)-16.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 17.43
Fwd PE 13.32
P/S 1.2
P/FCF 17.49
P/OCF 6.43
P/B 1.38
P/tB 1.64
EV/EBITDA 7.95
EPS(TTM)0.37
EY5.74%
EPS(NY)0.48
Fwd EY7.51%
FCF(TTM)0.37
FCFY5.72%
OCF(TTM)1
OCFY15.54%
SpS5.39
BVpS4.66
TBVpS3.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROCE 7.31%
ROIC 5.24%
ROICexc 5.64%
ROICexgc 6.28%
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
FCFM 6.85%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ROICexc(3y)14.67%
ROICexc(5y)11.45%
ROICexgc(3y)16.24%
ROICexgc(5y)12.7%
ROCE(3y)19.96%
ROCE(5y)15.59%
ROICexcg growth 3Y-15.7%
ROICexcg growth 5Y-1.81%
ROICexc growth 3Y-15.48%
ROICexc growth 5Y-2.08%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Debt/EBITDA 1.92
Cap/Depr 136.79%
Cap/Sales 11.76%
Interest Coverage 6.21
Cash Conversion 97.66%
Profit Quality 129.7%
Current Ratio 1.75
Quick Ratio 1.05
Altman-Z 2.41
F-Score5
WACC7.72%
ROIC/WACC0.68
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
EPS Next Y-3.39%
EPS Next 2Y12.89%
EPS Next 3Y12.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%
Revenue Next Year2.87%
Revenue Next 2Y4.16%
Revenue Next 3Y3.93%
Revenue Next 5YN/A
EBIT growth 1Y-7.97%
EBIT growth 3Y-13.49%
EBIT growth 5Y0.95%
EBIT Next Year73.14%
EBIT Next 3Y23.84%
EBIT Next 5YN/A
FCF growth 1Y-57.35%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-29.9%
OCF growth 3Y11.29%
OCF growth 5Y8.15%